Fluoptics Opens US Office
To market and sell its offerings for preclinical in vivo fluorescence imaging, Grenoble, France-based Fluoptics has opened an office in Cambridge, Mass. The company develops solutions that combine a nonradioactive fluorescent tracer targeting cancer cells with its Fluobeam real-time optical imaging system. The device, due to enter clinical trials this year in Europe, is available to the preclinical research market. “We will now work on accelerating the distribution of our preclinical instruments in the US and Canada directly or through key partnerships,” said Odile Allard, CEO of Fluoptics. The technology will illuminate cancer cells in real time during surgery.
- The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
MORE FROM PHOTONICS MEDIA